Elementis Bundle

What is the history of Elementis?
Elementis plc, a global specialty chemicals company, began its journey in 1844 as a tea and coffee merchant. Founded as Harrisons & Crosfield, it evolved significantly over the years.

The company transformed from a broad conglomerate into a focused producer of high-performance additives. In 1998, it officially became Elementis, marking a strategic shift to its core chemical expertise.
Elementis is now a leader in areas like chromium chemicals and rheological additives. For instance, its additives are crucial in enhancing personal care products. In 2024, Elementis achieved $738.3 million in revenue, with an adjusted operating profit of $129 million, reflecting a 17.4% operating margin.
What is the Elementis Founding Story?
The Elementis company history officially commenced on January 1, 1844, with a partnership formed in Liverpool, United Kingdom. This venture was established by Daniel Harrison, Smith Harrison, and Joseph Crosfield, laying the groundwork for what would become a significant player in various industries.
Elementis origins trace back to a partnership focused on the lucrative tea and coffee markets. The founders, Daniel and Smith Harrison, were established tea merchants, joined by the ambitious Joseph Crosfield.
- The firm, initially named Harrisons & Crosfield (H&C), began trading tea (80%) and coffee (20%).
- Their primary import sources were China for tea and South America for coffee.
- This merchanting model formed the core of their operations until the late 19th century.
- The business was influenced by Britain's growing international trade position.
The founding of Harrisons & Crosfield was a strategic response to the expanding global trade opportunities of the mid-19th century. While specific details on initial funding are limited, the partnership structure suggests reliance on the founders' existing capital and networks. A key early challenge for the Elementis company history was navigating a competitive trading environment. To address this, the firm relocated its headquarters to London in 1854, a move that proved pivotal. By the 1860s, H&C had risen to become the third-largest tea trader, demonstrating significant growth and establishing a strong market presence. This period of expansion and strategic repositioning was crucial for the Elementis evolution. The firm later transitioned into a limited-liability company, Harrisons & Crosfield Ltd., in 1908, marking a formal step in its corporate development and further solidifying its place in the Competitors Landscape of Elementis.
Elementis SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format

What Drove the Early Growth of Elementis?
The early history of the company, then known as Harrisons & Crosfield, showcases a dynamic journey from trading to significant industrial expansion. This period laid the groundwork for its future as a global specialty chemicals provider.
Under new management in the late 19th century, Harrisons & Crosfield moved beyond its initial tea and coffee trading. Strategic diversification led to plantation ownership starting in 1894, a pivotal shift that enabled the company to blend its own tea under the 'Nectar' brand and build a substantial export business.
The company's expansion continued into the rubber market in 1903, acquiring tea estates and developing rubber plantations. Further broadening its scope, it entered the timber sector in 1920 by acquiring the China Borneo Company and began producing Linatex, an abrasion-resistant rubber, in 1923. The launch of the Harcros chain of builders' merchants in 1935 marked another significant step in diversifying its operations.
A crucial turning point in the Elementis history occurred in 1947 with the commencement of chemical manufacturing through a joint venture with Durham Chemicals. Harrisons & Crosfield gained full control of this venture in 1963, signaling a definitive pivot towards the chemical industry. This strategic move would profoundly shape the company's future trajectory.
The company solidified its presence in chromium chemicals through significant acquisitions, including British Chrome & Chemicals in 1973 and American Chrome & Chemicals in 1979. Harrisons & Crosfield plc went public in 1982, a period characterized by the divestment of plantation interests, with three large plantation groups sold for £146 million. Further diversification occurred with the acquisition of Pauls in 1985 and Associated British Maltsters in 1987 for £14 million. By 1988, its chemical operations were consolidated under the Harcros Chemical Group, a key milestone in its Elementis company history.
Elementis PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable

What are the key Milestones in Elementis history?
Elementis, tracing its origins back to Harrisons & Crosfield, has undergone a significant transformation, marked by strategic shifts, key acquisitions, and adaptation to market dynamics. The company's journey reflects a deliberate move towards specialization in the chemical sector.
Year | Milestone |
---|---|
1998 | Divested non-chemical units and rebranded as Elementis plc, focusing exclusively on specialty chemicals. |
1998 | Acquired Rheox for $465 million, becoming the world's largest producer of rheological additives for coatings. |
2017 | Acquired SummitReheis for $360 million, bolstering its personal care segment, particularly in antiperspirant active ingredients. |
2024 | Reported a 3% revenue increase to $738 million and a 24% rise in adjusted operating profit to $129 million. |
2025 | Agreed to sell its Talc business to IMI Fabi for an enterprise value of $121 million. |
Elementis has consistently pursued innovation, notably with the acquisition of Rheox, which significantly strengthened its position in high-margin coatings and personal care markets. The company also launched nine new products in the first half of 2024, contributing $29 million in new business.
In 1998, Elementis completed a major strategic pivot by divesting its non-chemical businesses. This move allowed the company to concentrate its resources and expertise solely on the specialty chemicals sector, a crucial step in its evolution.
The acquisition of Rheox in 1998 was a landmark event, establishing Elementis as the global leader in rheological additives. This acquisition significantly expanded its product portfolio and market reach within the coatings industry.
The 2017 acquisition of SummitReheis marked a substantial enhancement of Elementis's personal care business. This strategic move bolstered its offerings in active ingredients for antiperspirants and broadened its international footprint.
Elementis is actively working towards environmental sustainability, with targets for a 25% reduction in Scope 1 and 2 emissions by 2030 and achieving net-zero emissions by 2050. This aligns with global efforts to combat climate change.
In the first half of 2024, Elementis demonstrated its commitment to innovation by launching nine new products. These new offerings contributed $29 million in new business, showcasing the company's ability to adapt to market needs.
Elementis has implemented efficiency programs to drive growth and profitability. The company delivered $18 million in annual cost savings in 2024 and anticipates an additional $12 million in savings in 2025, enhancing its operational performance.
Elementis has faced significant challenges, including intense competition in its chromium chemicals segment and a period of share price decline in the early 2000s, which led to consideration of a sale. More recently, the company incurred a $126 million impairment charge related to its Talc business in 2024, resulting in a statutory operating loss, prompting a strategic review and subsequent sale agreement.
In the early 2000s, Elementis contended with competitive pressures in its chromium chemicals division. This, coupled with a declining share price, led the company to explore strategic options, including a potential sale in 2001.
A significant challenge in 2024 was a $126 million impairment charge impacting the Talc business, leading to a statutory operating loss. This necessitated a strategic review of the segment, culminating in an agreement for its sale.
Despite recent positive financial results driven by internal initiatives, Elementis operates within a challenging global demand environment. The company's ability to adapt and execute its Growth Strategy of Elementis remains critical for sustained success.
Elementis Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout

What is the Timeline of Key Events for Elementis?
The Elementis company history is a fascinating journey from its origins as a tea and coffee merchant to its current position as a global specialty chemicals company. This evolution showcases significant strategic shifts and key acquisitions that have shaped its business.
Year | Key Event |
---|---|
1844 | Harrisons & Crosfield (H&C) was founded in Liverpool as a tea and coffee merchant. |
1908 | H&C converted into a limited-liability company, Harrisons & Crosfield Ltd. |
1947 | H&C entered chemical manufacturing through a joint venture with Durham Chemicals. |
1982 | The company went public as Harrisons & Crosfield plc after selling large plantation groups. |
1998 | The company officially changed its name to Elementis plc, focusing exclusively on specialty chemicals, and acquired Rheox for $465 million. |
2017 | Elementis acquired SummitReheis for $360 million, strengthening its personal care segment. |
2023 | Elementis announced seven growth platforms targeting $90 million in incremental revenue by 2026 and efficiency programs for $30 million in annual savings by 2025. |
2024 | Full year results reported revenue of $738 million and adjusted operating profit of $129 million. Interim results for H1 2024 showed revenue up 5% to $383 million and adjusted operating profit up 24% to $65 million. |
2025 | Elementis reported Q1 2025 performance with adjusted operating profit and margins ahead of Q1 2024. The sale of its Talc business to IMI Fabi for $121 million was announced, with net cash proceeds of approximately $55 million. A new Chief Executive Officer was appointed in March 2025. |
Elementis is focused on seven key growth platforms to drive future revenue. The company aims for significant incremental revenue growth by 2026 through these initiatives.
The company is implementing efficiency programs targeting substantial annual savings by 2025. These efforts are designed to improve profitability and operational effectiveness.
Elementis is actively managing its business portfolio, as evidenced by the sale of its Talc business. This strategic move allows for a greater focus on core specialty chemical operations.
Looking ahead, Elementis is targeting specific financial metrics including an adjusted operating profit margin of 19%+. The company is also investing in innovation with new product introductions and consolidating its manufacturing footprint to support future growth and manage market dynamics, such as potential impacts from US tariffs.
Elementis Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked

- What is Competitive Landscape of Elementis Company?
- What is Growth Strategy and Future Prospects of Elementis Company?
- How Does Elementis Company Work?
- What is Sales and Marketing Strategy of Elementis Company?
- What are Mission Vision & Core Values of Elementis Company?
- Who Owns Elementis Company?
- What is Customer Demographics and Target Market of Elementis Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.